The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Paul, Weiss, Rifkind, Wharton & Garrison LLP

2001 K STREET, NW, WASHINGTON, DC 20006-1047, USA
Work +1 202 223 7300
Fax +1 202 223 7420
Beijing, Hong Kong, London, New York, Tokyo, Toronto and 2 more

Kenneth A. Gallo

Work 202-223-7356
Paul, Weiss, Rifkind, Wharton & Garrison LLP

Work Department

Litigation, Antitrust, IP Litigation: Patent & Other Scientific, IP Litigation: Copyright & Trademark




J.D., University of Georgia School of Law, 1982 cum laude; B.A., University of Georgia, 1978 magna cum laude

United States: Antitrust

Civil litigation/class actions

Within: Civil litigation/class actions

Paul, Weiss, Rifkind, Wharton & Garrison LLP has seen its fair share of cases in sectors that have been active on the antitrust litigation front. In financial services, firm chairman Brad Karp and Andrew Finch led advice to Deutsche Bank in the international investigations and follow-on class actions relating to the bank’s role in the LIBOR manipulation scandal. In pharmaceuticals, Joseph Simons and Aidan Synnott are representing Pfizer in the settlement of a class action alleging monopolistic practices concerning its anti-seizure drug Neurontin. In sports, Simons and Daniel Toal are defending Major League Baseball (MLB) in allegations, brought by a class of purchasers of television packages, that MLB is violating Sections 1 and 2 of the Sherman Act by conspiring to prohibit teams from broadcasting their individual games nationwide. Kenneth Gallo and Jacqueline Rubin are other names to note. Beth Wilkinson left in January 2016 to found a boutique trial firm.

[back to top]

United States: Intellectual property

Patent litigation: full coverage

Within: Patent litigation: full coverage

Paul, Weiss, Rifkind, Wharton & Garrison LLP’s ‘highly responsive’ team has strong experience in the life sciences sector. Highlights included acting for Amgen in infringement and unfair competition litigation against Sandoz, successfully obtaining an injunction preventing the launch of Zarxio, a biosimilar of Amgen’s Neupogen product. The group is currently representing Biogen in a suit against several competitors regarding a patent covering Avonex, an MS treatment. Practice chair Nicholas Groombridge is ‘a top-notch patent trial lawyer’ and ‘an excellent strategic adviser’, and Catherine Nyarady is ‘very focused on trial’, and has ‘a great work ethic’. Washington DC-based David Ball has notable tech expertise, and Kenneth Gallo is also recommended.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to